NEW YORK (GenomeWeb) –Lucigen said today that it has signed a global agreement with Illumina for Lucigen to be the sole distributor of Epicentre Technologies' genomics kits, enzymes, and ancillary reagents.

Products covered by the new agreement are in addition to select Epicentre products that were licensed and transferred to Lucigen for manufacture and distribution in December, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.